Blog
Radioactive Waste Management: Containers & Compliance in Nuclear Medicine
Nuclear medicine generates roughly 90% of all hospital radioactive waste, yet most departments treat waste disposal as an afterthought. Under NRC 10 CFR 35.92 (and equivalent IAEA / national regulations), short-half-life waste (Tc-99m, F-18, Ga-68, I-131, Lu-177) can decay in storage for a minimum of 10 half-lives, then be surveyed at the unshielded surface and released as ordinary trash — provided every radiation label is removed. This guide walks through the four waste streams in a typical NM department (solid syringe/vial waste, liquid waste, sealed-source returns, volatile I-131), the container spec each stream needs (shielded, leak-proof, color-coded, dated), the half-life segregation principle that keeps Tc-99m from "contaminating" a Lu-177 barrel, the weekly survey-and-release workflow, and the enforcement traps that have cited real departments. We also map APEX shielded waste pots, lead-lined barrels and decay-in-storage cabinets to each waste stream.
PET Radiopharmacy 101: Equipment for FDG Production & Dispensing
[18F]FDG is the most-produced radiopharmaceutical on Earth, and every PET radiopharmacy — whether attached to a cyclotron or dispensing commercial doses — runs the same chain: cyclotron irradiation of oxygen-18 enriched water, automated nucleophilic synthesis in a shielded hot cell, cGMP QC on a 110-minute clock, and sterile dispensing in a Grade A isolator. This guide walks through the equipment at each step: the 16 MeV biomedical cyclotron with its niobium O-18 target, the synthesis module (TRACERlab, FASTlab, F300 class), the 40–50 mm lead-shielded hot cell, the automated dispenser, the dose calibrator, and the QC bench (radio-TLC, HPLC, gamma spectrometer, pH, endotoxin, bubble-point). We cover the FDG QC specification table — visual, pH 4.5–7.5, radiochemical purity >90%, residual Kryptofix ≤50 µg/mL, endotoxin <175/V EU/mL — and the 511 keV shielding physics that drives every wall thickness. APEX supplies the 511 keV shielding layer: 50 mm Pb PET L-benches, 8 mm tungsten syringe shields, 30 mm Pb vial shields and Type A shipping containers.
ALARA in Practice: Designing a Nuclear Medicine Hot Lab Workflow That Actually Protects Staff
This practical guide translates the ALARA (As Low As Reasonably Achievable) principle into an operational workflow for nuclear medicine hot labs. We cover the three-zone layout — hot dispensing, warm calibrator staging, and cold decay storage — and the nine-step receive-to-dispose chain that keeps technologists out of the line of sight on every draw. We map the equipment layer that closes the loop: L-blocks and L-benches, lead and tungsten vial shields, mmPb-matched tungsten syringe shields, long-handled shielded carriers, lead apparel, and lockable decay-in-storage waste pots. We then specify the dosimetry program — whole-body badge, non-dominant-hand ring badge, eye-lens dosimeter and electronic personal dosimeter — that reveals which workflow step actually drives extremity dose, and pin the design against the ICRP limits of 20 mSv whole body, 500 mSv extremity and 20 mSv eye lens per year. A quarterly ALARA audit checklist closes the loop for radiation safety officers and hot-lab managers.
Lead Aprons for Nuclear Medicine: What's Different from Radiology?
A lead apron is a lead apron — until you actually look at the photon energy it is built to stop. A radiology apron rated 0.25–0.35 mmPb is tuned to the soft scatter off a 60–120 kVp X-ray tube. A nuclear medicine technologist standing next to an FDG patient is facing 511 keV annihilation photons, where the lead HVL jumps from 0.26 mm (Tc-99m at 140 keV) to 4.0 mm (F-18). This guide explains why NM aprons are usually 0.5 mmPb minimum, why a wraparound cut beats a front-only apron for all-day wear, why the thyroid collar and leaded eyewear are non-negotiable additions that radiology departments skip, and how annual visual plus biennial fluoroscopic inspections — plus correct flat or wide-hanger storage — protect the investment. We also map APEX lead and lead-free aprons, thyroid collars and eyewear to SPECT, PET and therapy workflows.
Lead vs Tungsten: Choosing Syringe & Vial Shields for the Modern Hot Lab
Lead and tungsten are the two dominant gamma-shielding materials for nuclear medicine syringe and vial shields, but they are not interchangeable. Tungsten heavy alloy (17–19.25 g/cm³) delivers roughly 1.6× the density of lead (11.3 g/cm³), so a tungsten wall can be 25–50% thinner while matching lead's attenuation — cutting hand fatigue, improving needle control and eliminating lead's occupational toxicity. This guide compares the two materials on density, HVL, weight, durability, cost, ergonomics and beta-bremsstrahlung behavior, and gives radionuclide-specific recommendations: 2 mm tungsten for Tc-99m, 8 mm tungsten for F-18, and a tungsten-acrylic hybrid for Y-90 and Lu-177. We also flag the hidden failure mode of leaded-glass viewports and explain why the cheapest lead shield is often the most expensive one to operate. APEX supplies both lead and tungsten syringe and vial shields with certified mmPb ratings, matched to your dominant radionuclides.
Type A vs Type B Packaging for Radiopharmaceutical Transport
Choosing between Type A and Type B packaging is the highest-stakes compliance call in radiopharmaceutical transport. Under-pack and you risk enforcement; over-pack and a $200 courier shipment becomes a $20,000 cask project. This article explains the IAEA SSR-6 framework and how A1 (special-form) and A2 (normal-form) activity limits decide whether a shipment qualifies as Type A or must escalate to Type B(U)/B(M). It contrasts test regimes — Type A survives normal transport (0.9 m drop, water spray) while Type B must survive a 9 m drop, 800 °C fire and 15 m water immersion — and separates the two axes buyers confuse: package type (A/B) versus label category (White I / Yellow II / Yellow III, set by surface dose rate). The conclusion: ~95% of patient-dose FDG, Tc-99m, Ga-68, I-131 and Lu-177 shipments stop at Type A Yellow II; Type B is reserved for multi-Ci sealed sources and bulk production returns.
How to Choose Lead Equivalence (mmPb) for Your Radiopharmacy: The 2026 Buyer's Guide
This guide explains how to choose suitable lead equivalence (mmPb) shielding for radiopharmacy compounding, dispensing and storage. It covers core concepts of mmPb, HVL, shielding differences for gamma and beta emitters such as F-18, Ga-68, Tc-99m and Y-90, tungsten-to-lead equivalence conversion, bremsstrahlung risk control, and practical selection guidance. It also introduces APEX radiopharmacy shielding products, including tungsten syringe shields, lead equivalent storage containers and radiation protective garments to help labs meet radiation safety and ALARA requirements.
New IAEA Guidelines on Radiopharmaceutical Transport
The IAEA has updated its transport regulations for radioactive materials. Here's what changed and how it affects your operations.